首页> 美国卫生研究院文献>Scientific Reports >Long-term lifestyle interventions in middle-aged and elderly men with nonalcoholic fatty liver disease: a randomized controlled trial
【2h】

Long-term lifestyle interventions in middle-aged and elderly men with nonalcoholic fatty liver disease: a randomized controlled trial

机译:非酒精性脂肪肝疾病的中老年男性的长期生活方式干预:一项随机对照试验

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Nonalcoholic fatty liver disease (NAFLD), a metabolic disorder related to insulin resistance and metabolic syndrome, has become a public health concern. Currently, the principal therapeutic modalities targeting NAFLD are lifestyle interventions. However, the efficacy of long-term lifestyle interventions in managing NAFLD remains largely unexplored. This study aimed to evaluate the efficacy of long-term lifestyle interventions in middle-aged and elderly men with NAFLD. All 280 eligible patients were randomized to the control or test group. Patients in the test group received counseling on diet and exercise from 2 physicians every 3 months via a phone call. Patients in the control group received only counseling in annual checkups without regular intervention. After the 2-year periodic intervention, body weight, abdominal circumference, ALT, TCH, LDL-C and HDL-C decreased in the test group. Specifically, the fatty liver index (FLI) and NAFLD-fibrosis score (NAFLD-FS) reduced markedly in the test group. However, in the control group, there was only a significant decrease in LDL-C, HDL-C and NAFLD-FS (P < 0.001). The liver steatosis grade of the test group decreased significantly, while it increased in the control group. In NAFLD, long-term lifestyle interventions exert an anti-obesity effect and attenuate liver dysfunction and steatosis.
机译:非酒精性脂肪肝疾病(NAFLD)是一种与胰岛素抵抗和代谢综合征相关的代谢性疾病,已成为公共卫生问题。目前,针对NAFLD的主要治疗方式是生活方式干预。但是,长期生活方式干预在管理NAFLD中的功效仍未得到充分探索。这项研究旨在评估长期生活方式干预对NAFLD中老年男性的疗效。所有280名合格患者均被随机分为对照组或测试组。测试组中的患者每3个月通过电话从2位医生那里获得饮食和运动方面的咨询。对照组患者仅接受年度体检辅导,无需定期干预。经过2年的定期干预后,测试组的体重,腹围,ALT,TCH,LDL-C和HDL-C降低。具体而言,在测试组中,脂肪肝指数(FLI)和NAFLD纤维化评分(NAFLD-FS)明显降低。然而,在对照组中,LDL-C,HDL-C和NAFLD-FS仅显着降低(P <0.001)。试验组的肝脂肪变性等级明显降低,而对照组则升高。在NAFLD中,长期的生活方式干预可产生抗肥胖作用,并减轻肝脏功能障碍和脂肪变性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号